BCL2L1 and melanoma: Correlation studies of gene expression and survival analysis of melanoma patients also demonstrated that Bcl-xL expression significantly correlates with the expression of IL-8 and other markers of melanoma progression, and that high levels of both Bcl-xL and IL-8 proteins are associated with poor prognosis [21].